Latest News about ABOS
Recent news which mentions ABOS
Earnings Scheduled For November 13, 2023
November 13, 2023
From Benzinga
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
From InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
From Benzinga
From Benzinga
From Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
From Benzinga
From Benzinga
Masimo, Acumen Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 18, 2023
From Benzinga
From Benzinga
From Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
From Benzinga
From InvestorPlace
From InvestorPlace
Why Is Argenx (ARGX) Stock Up 27% Today?
July 17, 2023
From InvestorPlace
Why Is Acumen Pharmaceuticals (ABOS) Stock Up 46% Today?
July 17, 2023
Tickers
ABOS
From InvestorPlace
From InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
From Benzinga
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 11, 2023
From Benzinga
From Benzinga
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
July 11, 2023
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.